Clinical trial
Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase…
NCT00004294 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004294 |
|---|---|
| Title | Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH University of Pittsburgh |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gaucher's Disease |
| Intervention type | Genetic |
| Interventions | human glucocerebrosidase gene into autologous peripheral blood stem cells |
| Enrollment | 15 |
| Start date | Nov 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: